ZEPBOUND 5mg/0.5ml (Tirzepatide Vials) 5mg/0.5ml

Zepbound is a dual GIP and GLP-1 receptor agonist used in the management of obesity and related conditions. It is prescribed for:

• Obesity (BMI ≥30): Helps achieve and maintain weight loss in adults with obesity.
• Overweight (BMI ≥27) with weight-related comorbidities: Assists in weight management for individuals with conditions such as type 2 diabetes, hypertension, or dyslipidemia.
• Moderate-to-severe obstructive sleep apnea (OSA) and obesity: Improves OSA symptoms in obese adults.

• Tirzepatide, the active ingredient in Zepbound, works by activating both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action improves glycemic control, reduces appetite, and increases satiety, leading to weight loss and improved metabolic health.

Zepbound may cause various side effects, ranging from common to serious or rare.

Common Side Effects

• Nausea: A frequent side effect that may occur as the body adjusts to the medication.
• Diarrhea: Some patients may experience loose stools or frequent bowel movements.
• Vomiting: Occasional vomiting may occur, particularly at the start of treatment.
• Constipation: Some individuals may experience difficulty passing stools.
• Injection site reactions: Redness, swelling, or itching at the injection site.
• Fatigue: A general feeling of tiredness or lack of energy.

Serious or Rare Side Effects

• Thyroid tumors: Zepbound may cause tumors in the thyroid, including thyroid cancer. Symptoms include a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath.
• Pancreatitis: Inflammation of the pancreas, which may cause severe abdominal pain, nausea, and vomiting.
• Hypoglycemia: Low blood sugar levels, especially when used in combination with other diabetes medications.
• Kidney problems: Changes in kidney function, including kidney failure, have been reported.
• Allergic reactions: Severe allergic reactions, including anaphylaxis, are rare but possible.

Zepbound should be used with caution and under medical supervision. Important precautions include:

• Allergic reactions: Do not use Zepbound if you have had a serious allergic reaction to tirzepatide or any of its ingredients.
• Thyroid cancer: Do not use Zepbound if you or any family member has had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Pancreatitis: Use with caution in patients with a history of pancreatitis.
• Kidney problems: Monitor kidney function regularly, especially in patients with a history of kidney disease.
• Hypoglycemia: Be cautious when using Zepbound with other diabetes medications that can cause low blood sugar.
• Pregnancy and breastfeeding: The safety of Zepbound in pregnancy and breastfeeding is unknown. Consult your healthcare provider.
• Storage: Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Zepbound may interact with other medications, requiring careful monitoring or avoidance.

Major Interactions (Avoid)

• Other tirzepatide-containing products: Avoid using Zepbound with other tirzepatide-containing medications to prevent overdose or adverse effects.
• GLP-1 receptor agonist medicines: Do not use Zepbound with any GLP-1 receptor agonist medicines to avoid potential interactions and increased side effects.

Moderate Interactions (Monitor Closely)

• Insulin: Monitor blood sugar levels closely when using Zepbound with insulin to avoid hypoglycemia.
• Sulfonylureas: Be cautious when combining Zepbound with sulfonylureas, as both can lower blood sugar levels.
• Other diabetes medications: Regularly monitor blood sugar levels when using Zepbound with other diabetes medications to adjust doses as needed.